The possible explanations for these effects were as follows: (1) lnc-KASRT could regulate multiple oncogene/anti-oncogene alternative splicing events, including KLF6, to promote osteosarcoma cell malignant behaviors. The gene discussed is KLF6; the disease is osteosarcoma.